Daihan Pharmaceutical Co.Ltd (023910) — Financial Flexibility Index
Daihan Pharmaceutical Co.Ltd (023910) has a Financial Flexibility Index of 0.40x as of September 2025. Free cash flow of ₩20.27 Billion (operating CF ₩9.47 Billion minus capex ₩10.79 Billion) represents 0% of total liabilities (₩50.75 Billion). Also explore Daihan Pharmaceutical Co.Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Daihan Pharmaceutical Co.Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Daihan Pharmaceutical Co.Ltd across 11 annual periods. Check Daihan Pharmaceutical Co.Ltd (023910) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Daihan Pharmaceutical Co.Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Daihan Pharmaceutical Co.Ltd. For the full company profile including market capitalisation, see market cap of Daihan Pharmaceutical Co.Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.06x | ₩51.44 Billion | ₩35.64 Billion | ₩48.42 Billion | ▼ -18.2% |
| 2023 | 1.30x | ₩60.14 Billion | ₩38.86 Billion | ₩46.28 Billion | ▲ +78.2% |
| 2022 | 0.73x | ₩37.62 Billion | ₩29.00 Billion | ₩51.58 Billion | ▼ -3.1% |
| 2021 | 0.75x | ₩52.47 Billion | ₩40.62 Billion | ₩69.73 Billion | ▲ +37.3% |
| 2020 | 0.55x | ₩38.99 Billion | ₩33.63 Billion | ₩71.17 Billion | ▼ -16.5% |
| 2019 | 0.66x | ₩52.57 Billion | ₩35.26 Billion | ₩80.08 Billion | ▼ -32.4% |
| 2018 | 0.97x | ₩91.63 Billion | ₩44.94 Billion | ₩94.39 Billion | ▲ +60.3% |
| 2017 | 0.61x | ₩41.50 Billion | ₩20.45 Billion | ₩68.52 Billion | ▼ -18.1% |
| 2016 | 0.74x | ₩49.82 Billion | ₩27.92 Billion | ₩67.36 Billion | ▲ +109.0% |
| 2015 | 0.35x | ₩21.94 Billion | ₩17.98 Billion | ₩61.99 Billion | ▲ +19.7% |
| 2014 | 0.30x | ₩19.95 Billion | ₩9.48 Billion | ₩67.52 Billion | — |